Advanced Micro Devices is downgraded to a Sell due to an unattractive risk/reward profile despite robust short-term growth.

TJX stock faces weak MarMaxx comps, slowing sales, and rich valuation risks amid macro pressures and store expansion. See ...

Financials and Materials fell 1.62% and 0.73%, respectively, on Wednesday, pushing both into oversold territory and bringing ...

UnitedHealth Group’s recovery is gaining traction, with improving MCR, two 2026 EPS guidance raises, and stronger cash flow.

Hon Hai Precision Industry Co., Ltd. is rated a Buy as AI-driven computing boosts margins and efficiency. Click here to read ...

Shares Russell Top 200 Growth ETF is maintained as a Buy, citing multi-year low valuations and robust earnings growth ...

NiSource Inc. remains a Buy despite recent underperformance, with shares down 14% since July. Learn more about NI stock here.

Zymeworks Inc. remains a Buy, leveraging validated technology, strong price momentum, and upcoming catalysts. Read more on ...

Shares of Alkermes ( ALKS ), a global biopharmaceutical company focused on neuroscience, tumbled just over 7% on Friday, ...

InterDigital's risk/reward is unattractive at current levels due to concentrated revenues, legal uncertainties, and rising ...

This article explores Nvidia and Palantir’s sovereign AI partnership and why McKinsey sees it as a major AI opportunity.

Acuity's Q3 earnings beat lifts shares, but valuation looks stretched. Click here to read the latest analysis of the AYI ...